Related Experiment Videos
Fenoterol increases erythropoietin concentrations during tocolysis
C H Gleiter1, K H Schreeb, S Goldbach
1Abteilung Klinische Pharmakologie, George-August-Universität, Göttingen, Germany.
British Journal of Clinical Pharmacology
|March 10, 1998
Summary
Selective beta2-adrenoceptor agonists, like fenoterol, significantly increase erythropoietin (EPO) production. This effect was observed in a clinical model, confirming fenoterol
Area of Science:
- Pharmacology
- Endocrinology
- Obstetrics
Background:
- Erythropoietin (EPO) is a key hormone regulating red blood cell production.
- Selective beta2-adrenoceptor agonists are used in clinical settings, such as tocolysis.
- Understanding the impact of these agonists on EPO production is crucial for clinical applications.
Purpose of the Study:
- To investigate the effect of selective beta2-adrenoceptor agonists on erythropoietin (EPO) production.
- To assess fenoterol's impact on EPO levels in a clinical tocolysis model.
Main Methods:
- Utilized routine tocolysis with fenoterol at a standard rate (2 microg/min).
- Employed a clinically accessible model for assessing drug effects.
- Monitored EPO and potassium concentrations over a 48-hour period.
Main Results:
- Fenoterol administration led to a significant doubling of EPO concentrations within 24 hours (P < 0.001).
- The elevated EPO levels persisted for the entire 48-hour observation period.
- A significant decrease in potassium concentrations was observed during fenoterol infusion; no increase in human placenta lactogen was noted.
Conclusions:
- Fenoterol effectively increases EPO concentrations, particularly following hemorrhage.
- The study confirms previous findings on fenoterol's EPO-stimulating properties.
- Pharmacological stimulation of EPO production prior to fenoterol treatment was not necessary in this model.